Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.15234893 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.79468527 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.75262817 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.60794108 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.60794108 |
6 | NIK/NF-kappaB signaling (GO:0038061) | 5.00466284 |
7 | neutrophil activation involved in immune response (GO:0002283) | 4.35347240 |
8 | cellular response to zinc ion (GO:0071294) | 4.32499213 |
9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.30199100 |
10 | positive regulation of B cell differentiation (GO:0045579) | 4.29496359 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07409545 |
12 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.99441011 |
13 | myeloid dendritic cell differentiation (GO:0043011) | 3.96511236 |
14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.95508353 |
15 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92635777 |
16 | T-helper 1 type immune response (GO:0042088) | 3.92625898 |
17 | myeloid dendritic cell activation (GO:0001773) | 3.92026808 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91004039 |
19 | regulation of B cell differentiation (GO:0045577) | 3.90939663 |
20 | negative thymic T cell selection (GO:0045060) | 3.78640951 |
21 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.77521027 |
22 | defense response to protozoan (GO:0042832) | 3.75053753 |
23 | * B cell receptor signaling pathway (GO:0050853) | 3.70510186 |
24 | immunoglobulin mediated immune response (GO:0016064) | 3.68461127 |
25 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64542756 |
26 | mature B cell differentiation (GO:0002335) | 3.64418813 |
27 | negative T cell selection (GO:0043383) | 3.60263039 |
28 | response to type I interferon (GO:0034340) | 3.57156919 |
29 | neutrophil activation (GO:0042119) | 3.57022121 |
30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56628577 |
31 | cellular response to type I interferon (GO:0071357) | 3.55570369 |
32 | type I interferon signaling pathway (GO:0060337) | 3.55570369 |
33 | macrophage activation involved in immune response (GO:0002281) | 3.49862564 |
34 | T cell migration (GO:0072678) | 3.48985101 |
35 | response to muramyl dipeptide (GO:0032495) | 3.47418334 |
36 | granulocyte activation (GO:0036230) | 3.46978768 |
37 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.46170686 |
38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.45677414 |
39 | regulation of necroptotic process (GO:0060544) | 3.44947407 |
40 | positive regulation of interleukin-2 production (GO:0032743) | 3.43445235 |
41 | B cell proliferation (GO:0042100) | 3.41497462 |
42 | mast cell activation (GO:0045576) | 3.39314082 |
43 | positive regulation of interferon-alpha production (GO:0032727) | 3.37316540 |
44 | response to protozoan (GO:0001562) | 3.36956948 |
45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36937433 |
46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36173637 |
47 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.35674706 |
48 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.34462135 |
49 | B cell homeostasis (GO:0001782) | 3.34085372 |
50 | positive regulation of type 2 immune response (GO:0002830) | 3.33625660 |
51 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.30936961 |
52 | response to interleukin-15 (GO:0070672) | 3.29212449 |
53 | positive thymic T cell selection (GO:0045059) | 3.28738120 |
54 | regulation of interferon-alpha production (GO:0032647) | 3.25591934 |
55 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25284643 |
56 | leukocyte aggregation (GO:0070486) | 3.24704898 |
57 | dendritic cell differentiation (GO:0097028) | 3.23767069 |
58 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.22388996 |
59 | ribosomal small subunit assembly (GO:0000028) | 3.18264274 |
60 | B cell mediated immunity (GO:0019724) | 3.17047536 |
61 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.15334303 |
62 | cellular response to interferon-gamma (GO:0071346) | 3.15293035 |
63 | respiratory burst (GO:0045730) | 3.14340743 |
64 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.14148248 |
65 | cellular response to interleukin-15 (GO:0071350) | 3.11476590 |
66 | response to peptidoglycan (GO:0032494) | 3.10576894 |
67 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.10311459 |
68 | natural killer cell mediated immunity (GO:0002228) | 3.10311459 |
69 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.10256643 |
70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10063783 |
71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08870397 |
72 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08858726 |
73 | mature B cell differentiation involved in immune response (GO:0002313) | 3.07803261 |
74 | detection of bacterium (GO:0016045) | 3.07796409 |
75 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.07546891 |
76 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07018728 |
77 | detection of other organism (GO:0098543) | 3.05542892 |
78 | negative regulation of necroptotic process (GO:0060546) | 3.04869030 |
79 | regulation of antigen processing and presentation (GO:0002577) | 3.01990284 |
80 | regulation of RIG-I signaling pathway (GO:0039535) | 3.01019461 |
81 | myeloid cell activation involved in immune response (GO:0002275) | 3.00747888 |
82 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00502022 |
83 | T cell homeostasis (GO:0043029) | 3.00088728 |
84 | positive regulation of B cell proliferation (GO:0030890) | 2.99652360 |
85 | regulation of T-helper cell differentiation (GO:0045622) | 2.98609382 |
86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97430421 |
87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97161218 |
88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97161218 |
89 | modulation by symbiont of host immune response (GO:0052553) | 2.97161218 |
90 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97161218 |
91 | modulation by symbiont of host defense response (GO:0052031) | 2.97161218 |
92 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97161218 |
93 | lymph node development (GO:0048535) | 2.96639428 |
94 | T cell costimulation (GO:0031295) | 2.96067042 |
95 | response to interferon-beta (GO:0035456) | 2.95989041 |
96 | thymic T cell selection (GO:0045061) | 2.95910120 |
97 | positive regulation of T cell cytokine production (GO:0002726) | 2.95364365 |
98 | positive regulation of interleukin-12 production (GO:0032735) | 2.93402772 |
99 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.91080357 |
100 | lymphocyte costimulation (GO:0031294) | 2.91039338 |
101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90687385 |
102 | regulation of tolerance induction (GO:0002643) | 2.90494564 |
103 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90220831 |
104 | germinal center formation (GO:0002467) | 2.90159778 |
105 | natural killer cell differentiation (GO:0001779) | 2.89751790 |
106 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.86325189 |
107 | positive regulation of macrophage differentiation (GO:0045651) | 2.86296190 |
108 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85378752 |
109 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83526723 |
110 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83063355 |
111 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.82920274 |
112 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.82704067 |
113 | cellular response to interferon-beta (GO:0035458) | 2.81993608 |
114 | negative regulation of cell killing (GO:0031342) | 2.81923781 |
115 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81923781 |
116 | regulation of T cell tolerance induction (GO:0002664) | 2.81794890 |
117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81051660 |
118 | response to interferon-gamma (GO:0034341) | 2.80802822 |
119 | regulation of B cell proliferation (GO:0030888) | 2.79495873 |
120 | negative regulation of interleukin-12 production (GO:0032695) | 2.78933162 |
121 | activation of MAPKKK activity (GO:0000185) | 2.78872649 |
122 | positive regulation of B cell activation (GO:0050871) | 2.78537538 |
123 | regulation of interleukin-12 production (GO:0032655) | 2.77563928 |
124 | myeloid leukocyte activation (GO:0002274) | 2.75956523 |
125 | T cell selection (GO:0045058) | 2.74762977 |
126 | T cell lineage commitment (GO:0002360) | 2.74710848 |
127 | leukocyte degranulation (GO:0043299) | 2.73549691 |
128 | positive regulation of humoral immune response (GO:0002922) | 2.72566425 |
129 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.72533686 |
130 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.72458939 |
131 | response to interferon-alpha (GO:0035455) | 2.72300289 |
132 | regulation of type 2 immune response (GO:0002828) | 2.71500063 |
133 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70906429 |
134 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.70497210 |
135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.69773438 |
136 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.69621836 |
137 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68748170 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.90631885 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.62833505 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.61791084 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.27663061 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.11096279 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67581609 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.66529489 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.36590706 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.33415497 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19769167 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01954008 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92301156 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90057070 |
14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83606817 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80677576 |
16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.73977640 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62804421 |
18 | * MYC_22102868_ChIP-Seq_BL_Human | 2.52853954 |
19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.48675973 |
20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.44025430 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.43759880 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42192513 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37990052 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34062250 |
25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33639465 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30441134 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28930459 |
28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20313981 |
29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.19845296 |
30 | * MYB_26560356_Chip-Seq_TH1_Human | 2.15314369 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07118395 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01213182 |
33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00503808 |
34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92841487 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90051639 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87659248 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87505432 |
38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83649323 |
39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81068741 |
40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78749621 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74087806 |
42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74059640 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70699123 |
44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70338639 |
45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69744213 |
46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64885529 |
47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60328340 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.59163466 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55959614 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53556575 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52406939 |
52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50454165 |
53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47976661 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47305129 |
55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.44255147 |
56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42819306 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40605707 |
58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40217339 |
59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38636545 |
60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37516024 |
61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37446212 |
62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37024976 |
63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36210333 |
64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35504197 |
65 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34558627 |
66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31444915 |
67 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29460135 |
68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27263295 |
69 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27140609 |
70 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.26210966 |
71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25136522 |
72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19978337 |
73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18487040 |
74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18085695 |
75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16916231 |
76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16732800 |
77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16053107 |
78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14246055 |
79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14087788 |
80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13172497 |
81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11525788 |
82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09580372 |
83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07537739 |
84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06859419 |
85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06131213 |
86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04391949 |
87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03839402 |
88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01173604 |
89 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99515817 |
90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98788623 |
91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96853823 |
92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96810571 |
93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94076314 |
94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92749105 |
95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92483221 |
96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92197602 |
97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90426152 |
98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.90349225 |
99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88472337 |
100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88274872 |
101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85800856 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83330644 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82293709 |
104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81432885 |
105 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81108717 |
106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79052889 |
107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76652198 |
108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75998398 |
109 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.75056121 |
110 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.74970060 |
111 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74291049 |
112 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74209141 |
113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.74048071 |
114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73792887 |
115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73589540 |
116 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72175583 |
117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71312751 |
118 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.69089216 |
119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68676725 |
120 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.68667512 |
121 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.67823784 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.82302721 |
2 | MP0000685_abnormal_immune_system | 3.93974882 |
3 | MP0001790_abnormal_immune_system | 3.43851612 |
4 | MP0005387_immune_system_phenotype | 3.43851612 |
5 | MP0005671_abnormal_response_to | 3.30792784 |
6 | * MP0001800_abnormal_humoral_immune | 3.18086436 |
7 | * MP0005000_abnormal_immune_tolerance | 3.07160164 |
8 | MP0002148_abnormal_hypersensitivity_rea | 3.01780434 |
9 | MP0004510_myositis | 2.96375301 |
10 | MP0009785_altered_susceptibility_to | 2.94397604 |
11 | * MP0002452_abnormal_antigen_presenting | 2.93807630 |
12 | MP0003436_decreased_susceptibility_to | 2.89081323 |
13 | MP0003303_peritoneal_inflammation | 2.82519269 |
14 | * MP0002723_abnormal_immune_serum | 2.80743171 |
15 | MP0005025_abnormal_response_to | 2.74058981 |
16 | * MP0002420_abnormal_adaptive_immunity | 2.66421417 |
17 | * MP0001819_abnormal_immune_cell | 2.65155432 |
18 | MP0002419_abnormal_innate_immunity | 2.63569775 |
19 | MP0002166_altered_tumor_susceptibility | 2.56869619 |
20 | MP0003763_abnormal_thymus_physiology | 2.41075466 |
21 | * MP0002398_abnormal_bone_marrow | 2.32304234 |
22 | MP0003724_increased_susceptibility_to | 2.25059514 |
23 | * MP0000716_abnormal_immune_system | 2.19310542 |
24 | MP0002006_tumorigenesis | 2.12961120 |
25 | MP0006082_CNS_inflammation | 2.10046859 |
26 | MP0002396_abnormal_hematopoietic_system | 2.06932509 |
27 | MP0002405_respiratory_system_inflammati | 2.00554280 |
28 | MP0001853_heart_inflammation | 1.97074766 |
29 | MP0005464_abnormal_platelet_physiology | 1.94252137 |
30 | * MP0000689_abnormal_spleen_morphology | 1.87661922 |
31 | MP0001873_stomach_inflammation | 1.84275651 |
32 | * MP0002429_abnormal_blood_cell | 1.82256662 |
33 | MP0002722_abnormal_immune_system | 1.81716685 |
34 | MP0010155_abnormal_intestine_physiology | 1.78078213 |
35 | MP0005310_abnormal_salivary_gland | 1.74530748 |
36 | MP0001348_abnormal_lacrimal_gland | 1.72999632 |
37 | MP0005058_abnormal_lysosome_morphology | 1.71092418 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.69930550 |
39 | MP0008438_abnormal_cutaneous_collagen | 1.65799762 |
40 | MP0001845_abnormal_inflammatory_respons | 1.65062435 |
41 | MP0005451_abnormal_body_composition | 1.64823956 |
42 | MP0004808_abnormal_hematopoietic_stem | 1.61774120 |
43 | MP0004947_skin_inflammation | 1.59989713 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.59271844 |
45 | MP0002933_joint_inflammation | 1.53140239 |
46 | MP0005397_hematopoietic_system_phenotyp | 1.51267976 |
47 | MP0001545_abnormal_hematopoietic_system | 1.51267976 |
48 | MP0003300_gastrointestinal_ulcer | 1.48839150 |
49 | MP0005174_abnormal_tail_pigmentation | 1.48293572 |
50 | MP0000703_abnormal_thymus_morphology | 1.44768242 |
51 | MP0001533_abnormal_skeleton_physiology | 1.42063792 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.31802332 |
53 | MP0008469_abnormal_protein_level | 1.31675387 |
54 | MP0003866_abnormal_defecation | 1.29082399 |
55 | MP0003448_altered_tumor_morphology | 1.26614508 |
56 | MP0003172_abnormal_lysosome_physiology | 1.23997481 |
57 | MP0002009_preneoplasia | 1.22710276 |
58 | MP0009278_abnormal_bone_marrow | 1.19282401 |
59 | MP0008057_abnormal_DNA_replication | 1.10233678 |
60 | MP0003828_pulmonary_edema | 1.08168511 |
61 | MP0000343_altered_response_to | 1.07937857 |
62 | MP0003705_abnormal_hypodermis_morpholog | 1.06308322 |
63 | MP0002254_reproductive_system_inflammat | 1.06230414 |
64 | MP0003183_abnormal_peptide_metabolism | 1.06229197 |
65 | MP0002998_abnormal_bone_remodeling | 1.03749770 |
66 | MP0005623_abnormal_meninges_morphology | 1.03248998 |
67 | MP0002332_abnormal_exercise_endurance | 1.03029537 |
68 | MP0001542_abnormal_bone_strength | 1.00773532 |
69 | MP0003045_fibrosis | 0.99865639 |
70 | MP0002139_abnormal_hepatobiliary_system | 0.96815137 |
71 | MP0008004_abnormal_stomach_pH | 0.96070669 |
72 | MP0008874_decreased_physiological_sensi | 0.95790133 |
73 | MP0000490_abnormal_crypts_of | 0.94855311 |
74 | MP0000858_altered_metastatic_potential | 0.93966684 |
75 | MP0009764_decreased_sensitivity_to | 0.91239717 |
76 | MP0010352_gastrointestinal_tract_polyps | 0.88619715 |
77 | MP0000015_abnormal_ear_pigmentation | 0.85606456 |
78 | MP0003656_abnormal_erythrocyte_physiolo | 0.84701528 |
79 | MP0009840_abnormal_foam_cell | 0.83329219 |
80 | MP0003690_abnormal_glial_cell | 0.83238465 |
81 | MP0005275_abnormal_skin_tensile | 0.79121897 |
82 | MP0002019_abnormal_tumor_incidence | 0.79075173 |
83 | MP0001879_abnormal_lymphatic_vessel | 0.79002957 |
84 | MP0005075_abnormal_melanosome_morpholog | 0.78505845 |
85 | MP0001851_eye_inflammation | 0.77984769 |
86 | MP0005164_abnormal_response_to | 0.76919988 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.76728785 |
88 | MP0009763_increased_sensitivity_to | 0.73454422 |
89 | MP0002095_abnormal_skin_pigmentation | 0.73303710 |
90 | MP0003091_abnormal_cell_migration | 0.73266469 |
91 | MP0003566_abnormal_cell_adhesion | 0.73144580 |
92 | MP0000920_abnormal_myelination | 0.72929093 |
93 | MP0004883_abnormal_blood_vessel | 0.72759651 |
94 | MP0008260_abnormal_autophagy | 0.70707548 |
95 | MP0000249_abnormal_blood_vessel | 0.67507453 |
96 | MP0003075_altered_response_to | 0.66749078 |
97 | MP0005165_increased_susceptibility_to | 0.66589116 |
98 | MP0003279_aneurysm | 0.65742487 |
99 | MP0005375_adipose_tissue_phenotype | 0.64995686 |
100 | MP0006054_spinal_hemorrhage | 0.64494420 |
101 | MP0003329_amyloid_beta_deposits | 0.63619066 |
102 | MP0005666_abnormal_adipose_tissue | 0.62908322 |
103 | MP0003646_muscle_fatigue | 0.62562126 |
104 | MP0001663_abnormal_digestive_system | 0.62277142 |
105 | MP0000767_abnormal_smooth_muscle | 0.62065929 |
106 | MP0005390_skeleton_phenotype | 0.59573975 |
107 | MP0000604_amyloidosis | 0.59374969 |
108 | MP0003191_abnormal_cellular_cholesterol | 0.58357612 |
109 | MP0005166_decreased_susceptibility_to | 0.58265156 |
110 | MP0002877_abnormal_melanocyte_morpholog | 0.57386673 |
111 | MP0002277_abnormal_respiratory_mucosa | 0.54916338 |
112 | MP0001958_emphysema | 0.54777961 |
113 | MP0003453_abnormal_keratinocyte_physiol | 0.54204769 |
114 | MP0003795_abnormal_bone_structure | 0.54036100 |
115 | MP0002163_abnormal_gland_morphology | 0.52722510 |
116 | MP0000313_abnormal_cell_death | 0.52593334 |
117 | MP0005023_abnormal_wound_healing | 0.52290798 |
118 | MP0000569_abnormal_digit_pigmentation | 0.51839452 |
119 | MP0010307_abnormal_tumor_latency | 0.49735203 |
120 | MP0000371_diluted_coat_color | 0.49713283 |
121 | MP0002136_abnormal_kidney_physiology | 0.48641564 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.61880041 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.35177093 |
3 | Eczematoid dermatitis (HP:0000976) | 5.27001597 |
4 | Chronic otitis media (HP:0000389) | 4.97796369 |
5 | Recurrent viral infections (HP:0004429) | 4.49374021 |
6 | Agammaglobulinemia (HP:0004432) | 4.47589520 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42194869 |
8 | Recurrent fungal infections (HP:0002841) | 4.40706834 |
9 | Recurrent bronchitis (HP:0002837) | 4.21357665 |
10 | Cellulitis (HP:0100658) | 4.20555311 |
11 | Recurrent skin infections (HP:0001581) | 4.16769253 |
12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.99009983 |
13 | Myositis (HP:0100614) | 3.87126747 |
14 | Panhypogammaglobulinemia (HP:0003139) | 3.83593445 |
15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.79834755 |
16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.79834755 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.75588106 |
18 | IgM deficiency (HP:0002850) | 3.72444091 |
19 | Gastrointestinal stroma tumor (HP:0100723) | 3.64591676 |
20 | Thrombocytosis (HP:0001894) | 3.64153572 |
21 | Abnormality of macrophages (HP:0004311) | 3.61781908 |
22 | Vasculitis (HP:0002633) | 3.55558593 |
23 | Meningitis (HP:0001287) | 3.49617830 |
24 | Inflammation of the large intestine (HP:0002037) | 3.35439016 |
25 | Autoimmune thrombocytopenia (HP:0001973) | 3.30657292 |
26 | Colitis (HP:0002583) | 3.29215957 |
27 | Stomatitis (HP:0010280) | 3.28765359 |
28 | Nasal polyposis (HP:0100582) | 3.26372237 |
29 | Abnormality of T cell physiology (HP:0011840) | 3.23887484 |
30 | Gastrointestinal inflammation (HP:0004386) | 3.18597162 |
31 | Abnormality of T cell number (HP:0011839) | 3.18041512 |
32 | Abnormality of the nasal mucosa (HP:0000433) | 3.16402697 |
33 | Obstructive lung disease (HP:0006536) | 3.14643722 |
34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14643722 |
35 | Abnormality of T cells (HP:0002843) | 3.14466351 |
36 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11133403 |
37 | Fatigue (HP:0012378) | 3.07094667 |
38 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05868546 |
39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05868546 |
40 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05868546 |
41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.04583519 |
42 | Lymphopenia (HP:0001888) | 3.02438264 |
43 | T lymphocytopenia (HP:0005403) | 2.98550075 |
44 | Spontaneous hematomas (HP:0007420) | 2.95032927 |
45 | Petechiae (HP:0000967) | 2.91334755 |
46 | Retrobulbar optic neuritis (HP:0100654) | 2.89298171 |
47 | Optic neuritis (HP:0100653) | 2.89298171 |
48 | IgG deficiency (HP:0004315) | 2.88367449 |
49 | Systemic lupus erythematosus (HP:0002725) | 2.86938871 |
50 | Emphysema (HP:0002097) | 2.84509993 |
51 | Increased IgE level (HP:0003212) | 2.80126512 |
52 | Orchitis (HP:0100796) | 2.78932413 |
53 | Osteomyelitis (HP:0002754) | 2.78371578 |
54 | Increased IgM level (HP:0003496) | 2.74155651 |
55 | Pulmonary infiltrates (HP:0002113) | 2.71809638 |
56 | Leukocytosis (HP:0001974) | 2.68614519 |
57 | Interstitial pulmonary disease (HP:0006530) | 2.67995046 |
58 | Prolonged bleeding time (HP:0003010) | 2.65983759 |
59 | Chronic sinusitis (HP:0011109) | 2.65609976 |
60 | Gingivitis (HP:0000230) | 2.64881988 |
61 | Hypergammaglobulinemia (HP:0010702) | 2.64817620 |
62 | Vacuolated lymphocytes (HP:0001922) | 2.60692829 |
63 | Pustule (HP:0200039) | 2.59138515 |
64 | Recurrent pneumonia (HP:0006532) | 2.57888539 |
65 | Recurrent lower respiratory tract infections (HP:0002783) | 2.57406455 |
66 | Hematochezia (HP:0002573) | 2.55895788 |
67 | Gingival bleeding (HP:0000225) | 2.55085466 |
68 | Recurrent sinusitis (HP:0011108) | 2.53367356 |
69 | Epistaxis (HP:0000421) | 2.50909032 |
70 | Eosinophilia (HP:0001880) | 2.50200291 |
71 | IgA deficiency (HP:0002720) | 2.48757113 |
72 | Abnormality of the peritoneum (HP:0002585) | 2.48695022 |
73 | Basal ganglia calcification (HP:0002135) | 2.47424808 |
74 | Granulocytopenia (HP:0001913) | 2.39853784 |
75 | Papilloma (HP:0012740) | 2.39794240 |
76 | Verrucae (HP:0200043) | 2.39794240 |
77 | Dysostosis multiplex (HP:0000943) | 2.39028174 |
78 | Hypertensive crisis (HP:0100735) | 2.37962092 |
79 | Chest pain (HP:0100749) | 2.36507958 |
80 | Thyroiditis (HP:0100646) | 2.35474536 |
81 | Arterial thrombosis (HP:0004420) | 2.34977441 |
82 | Loss of speech (HP:0002371) | 2.34847884 |
83 | Increased cerebral lipofuscin (HP:0011813) | 2.30045805 |
84 | Hemoptysis (HP:0002105) | 2.28419166 |
85 | Autoimmune hemolytic anemia (HP:0001890) | 2.28416643 |
86 | Abnormality of eosinophils (HP:0001879) | 2.27707389 |
87 | B lymphocytopenia (HP:0010976) | 2.26250740 |
88 | Abnormality of B cell number (HP:0010975) | 2.26250740 |
89 | Periodontitis (HP:0000704) | 2.25737341 |
90 | Arthralgia (HP:0002829) | 2.24897397 |
91 | Restrictive lung disease (HP:0002091) | 2.23312994 |
92 | Encephalitis (HP:0002383) | 2.22093493 |
93 | Spondylolisthesis (HP:0003302) | 2.21782313 |
94 | Keratoconjunctivitis sicca (HP:0001097) | 2.21232520 |
95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20700109 |
96 | Skin ulcer (HP:0200042) | 2.20222561 |
97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19321286 |
98 | Bronchitis (HP:0012387) | 2.18122587 |
99 | Severe combined immunodeficiency (HP:0004430) | 2.16874651 |
100 | Abnormality of the fingertips (HP:0001211) | 2.16500933 |
101 | Viral hepatitis (HP:0006562) | 2.13937492 |
102 | Sepsis (HP:0100806) | 2.13216731 |
103 | Acrocyanosis (HP:0001063) | 2.11124584 |
104 | Lymphoma (HP:0002665) | 2.08208312 |
105 | Peritonitis (HP:0002586) | 2.07554667 |
106 | Urticaria (HP:0001025) | 2.06176521 |
107 | Dilatation of the ascending aorta (HP:0005111) | 2.04518356 |
108 | Chronic diarrhea (HP:0002028) | 2.02515657 |
109 | Abnormality of the prostate (HP:0008775) | 2.02263431 |
110 | Abnormality of the pleura (HP:0002103) | 2.00830700 |
111 | Thoracolumbar scoliosis (HP:0002944) | 1.98474719 |
112 | Gastrointestinal infarctions (HP:0005244) | 1.98270732 |
113 | Axonal loss (HP:0003447) | 1.98114169 |
114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98048117 |
115 | Osteolytic defects of the hand bones (HP:0009699) | 1.98048117 |
116 | Amaurosis fugax (HP:0100576) | 1.97378238 |
117 | Aortic aneurysm (HP:0004942) | 1.95420805 |
118 | Thin bony cortex (HP:0002753) | 1.95191172 |
119 | Keratoconjunctivitis (HP:0001096) | 1.94858275 |
120 | Protrusio acetabuli (HP:0003179) | 1.92307758 |
121 | Purpura (HP:0000979) | 1.80482429 |
122 | Pulmonary embolism (HP:0002204) | 1.80020858 |
123 | Glomerulopathy (HP:0100820) | 1.79716078 |
124 | Increased variability in muscle fiber diameter (HP:0003557) | 1.77957723 |
125 | Skin rash (HP:0000988) | 1.77804976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.75265236 |
2 | PRPF4B | 3.95253711 |
3 | MAP3K14 | 3.17770981 |
4 | TYK2 | 2.89314256 |
5 | JAK3 | 2.88707435 |
6 | TBK1 | 2.85323461 |
7 | BLK | 2.69188764 |
8 | KIT | 2.49683481 |
9 | IKBKB | 2.44882226 |
10 | IRAK4 | 2.39151923 |
11 | TXK | 2.30561513 |
12 | RIPK4 | 2.26592496 |
13 | IKBKE | 2.21492316 |
14 | NME2 | 2.21132434 |
15 | ZAP70 | 2.10595551 |
16 | EPHB1 | 2.06868439 |
17 | SYK | 1.99863424 |
18 | MAP3K13 | 1.97021394 |
19 | BTK | 1.97013134 |
20 | CSF1R | 1.90506964 |
21 | JAK1 | 1.89314440 |
22 | DDR2 | 1.82836240 |
23 | TEC | 1.72268904 |
24 | IRAK3 | 1.70541551 |
25 | TAOK2 | 1.64641111 |
26 | CDC42BPA | 1.63076480 |
27 | PIM2 | 1.60458353 |
28 | LRRK2 | 1.52911159 |
29 | LCK | 1.47494537 |
30 | MAP3K10 | 1.46009910 |
31 | NLK | 1.44054473 |
32 | STK10 | 1.40817901 |
33 | KDR | 1.40458159 |
34 | CHUK | 1.37464600 |
35 | GRK6 | 1.30397685 |
36 | HCK | 1.30041158 |
37 | TGFBR2 | 1.29373591 |
38 | MOS | 1.22481935 |
39 | PIM1 | 1.21775610 |
40 | CSK | 1.16501728 |
41 | TESK2 | 1.15908319 |
42 | LYN | 1.15562455 |
43 | SMG1 | 1.15488485 |
44 | BMPR2 | 1.14628282 |
45 | EEF2K | 1.14216998 |
46 | EPHA3 | 1.13268263 |
47 | ERN1 | 1.09813655 |
48 | RIPK1 | 1.07638232 |
49 | ITK | 1.07157194 |
50 | FES | 1.06734868 |
51 | FGFR4 | 1.05582524 |
52 | MAPK7 | 1.04584880 |
53 | ARAF | 1.03330050 |
54 | MAP2K3 | 0.99530595 |
55 | TGFBR1 | 0.99259160 |
56 | TTN | 0.98047133 |
57 | PDGFRA | 0.97387335 |
58 | JAK2 | 0.93911770 |
59 | STK4 | 0.93615337 |
60 | MAPKAPK5 | 0.89073054 |
61 | RPS6KA4 | 0.88782383 |
62 | CLK1 | 0.87736199 |
63 | MAPK12 | 0.86620764 |
64 | TRIB3 | 0.85835125 |
65 | PBK | 0.85749299 |
66 | PIK3CG | 0.83030554 |
67 | MAPK11 | 0.82378683 |
68 | SCYL2 | 0.80358324 |
69 | TAOK3 | 0.76170751 |
70 | PRKCQ | 0.73736780 |
71 | MST4 | 0.73331058 |
72 | MATK | 0.70164232 |
73 | HIPK2 | 0.69483058 |
74 | TRPM7 | 0.66244269 |
75 | FLT3 | 0.66037534 |
76 | MAP3K3 | 0.65542543 |
77 | CDK12 | 0.65467563 |
78 | CAMKK1 | 0.65414468 |
79 | PRKCH | 0.64480395 |
80 | TIE1 | 0.63349672 |
81 | IRAK1 | 0.63069895 |
82 | RPS6KA5 | 0.62161657 |
83 | SIK2 | 0.61923231 |
84 | FGFR3 | 0.61308872 |
85 | MUSK | 0.59715714 |
86 | NEK9 | 0.58064426 |
87 | MAPKAPK2 | 0.55952312 |
88 | MARK2 | 0.54536518 |
89 | MAP3K5 | 0.54398179 |
90 | PKN1 | 0.53094068 |
91 | RPS6KA2 | 0.52562704 |
92 | PKN2 | 0.51850850 |
93 | SIK1 | 0.51766836 |
94 | CAMKK2 | 0.51434208 |
95 | RPS6KC1 | 0.50794273 |
96 | RPS6KL1 | 0.50794273 |
97 | MAP3K11 | 0.50775650 |
98 | ABL1 | 0.50370128 |
99 | PDPK1 | 0.49814546 |
100 | MARK3 | 0.48893160 |
101 | DAPK3 | 0.48644824 |
102 | PRKCD | 0.47776013 |
103 | TAOK1 | 0.46581780 |
104 | ICK | 0.45855140 |
105 | EIF2AK3 | 0.44795557 |
106 | ILK | 0.44308453 |
107 | MYLK | 0.43565761 |
108 | STK24 | 0.42455976 |
109 | PRKD2 | 0.41769166 |
110 | PTK6 | 0.41700885 |
111 | ACVR1B | 0.38661905 |
112 | FGR | 0.37812672 |
113 | KSR2 | 0.37738901 |
114 | RPS6KA6 | 0.37679559 |
115 | EGFR | 0.36833084 |
116 | PRKD1 | 0.36457252 |
117 | TESK1 | 0.35167751 |
118 | CDK4 | 0.34484702 |
119 | INSR | 0.34282080 |
120 | GRK7 | 0.34169081 |
121 | TYRO3 | 0.33753707 |
122 | MELK | 0.33557429 |
123 | ALK | 0.33430628 |
124 | MAP3K12 | 0.32019260 |
125 | FYN | 0.31354436 |
126 | SIK3 | 0.31243528 |
127 | TNK2 | 0.29803543 |
128 | MAP3K1 | 0.29002507 |
129 | PDK1 | 0.28608552 |
130 | MAPK4 | 0.28118023 |
131 | DMPK | 0.26465012 |
132 | TLK1 | 0.26044205 |
133 | MAP3K8 | 0.24899681 |
134 | YES1 | 0.23970788 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.57687999 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95332398 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90206760 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.79860329 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72033462 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.71002189 |
7 | Measles_Homo sapiens_hsa05162 | 2.44745214 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40300578 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36257347 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28173423 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.13160813 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09832980 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06970453 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03603517 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01801002 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99907775 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78712427 |
18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77935058 |
19 | Asthma_Homo sapiens_hsa05310 | 1.73274331 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69587787 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69422720 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67365549 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62366077 |
24 | Malaria_Homo sapiens_hsa05144 | 1.60784492 |
25 | Pertussis_Homo sapiens_hsa05133 | 1.59903115 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.58678530 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57820468 |
28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57211309 |
29 | Shigellosis_Homo sapiens_hsa05131 | 1.55785665 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52450601 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.52436711 |
32 | Ribosome_Homo sapiens_hsa03010 | 1.49275077 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.49256624 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.46683102 |
35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42111995 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42078466 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38186290 |
38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35136610 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33551318 |
40 | Salmonella infection_Homo sapiens_hsa05132 | 1.23522013 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.20213677 |
42 | Platelet activation_Homo sapiens_hsa04611 | 1.14609754 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13668495 |
44 | DNA replication_Homo sapiens_hsa03030 | 1.13467862 |
45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07646482 |
46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02338856 |
47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00599720 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99403627 |
49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96147586 |
50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96121780 |
51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95923239 |
52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93359612 |
53 | Lysosome_Homo sapiens_hsa04142 | 0.92783563 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87111807 |
55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86634226 |
56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86349208 |
57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85447088 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82676221 |
59 | Hepatitis C_Homo sapiens_hsa05160 | 0.81389255 |
60 | Base excision repair_Homo sapiens_hsa03410 | 0.80724566 |
61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78253688 |
62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75852411 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71718911 |
64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71030102 |
65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70810960 |
66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70248755 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65004956 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.63412096 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.61665443 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57624712 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56673769 |
72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56329032 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51394421 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50568662 |
75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49300895 |
76 | Bladder cancer_Homo sapiens_hsa05219 | 0.48300515 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47373658 |
78 | Mismatch repair_Homo sapiens_hsa03430 | 0.46695293 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46575986 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.45301809 |
81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43471212 |
82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42668104 |
83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42160662 |
84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40794342 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40017370 |
86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39569878 |
87 | Focal adhesion_Homo sapiens_hsa04510 | 0.38589887 |
88 | Homologous recombination_Homo sapiens_hsa03440 | 0.36793509 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36446917 |
90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34409034 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.32395235 |
92 | Proteasome_Homo sapiens_hsa03050 | 0.31505080 |
93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31440544 |
94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30191514 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.29916673 |
96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29666984 |
97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29500251 |
98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28892291 |
99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27027506 |
100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26502185 |
101 | Glioma_Homo sapiens_hsa05214 | 0.26224717 |
102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26200856 |
103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26114367 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24931599 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.22899692 |
106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22486409 |
107 | Spliceosome_Homo sapiens_hsa03040 | 0.21276976 |
108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21217959 |
109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20761860 |
110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20727789 |
111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20224560 |
112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.20039729 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18511120 |
114 | RNA degradation_Homo sapiens_hsa03018 | 0.18247793 |
115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18145390 |
116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17651929 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17344295 |
118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15642139 |